Biomark Diagnostics
2007
FOUNDED
PUBLIC
STATUS
BUX
STOCK SYMBOL
$0.04
SHARE PRICE
(As of Thursday Closing)
Description
Biomark Diagnostics Inc is a Canada based oncology-focused company. It is engaged in the development of advanced stage cancer diagnostic business. The company develops non-invasive cancer diagnostic solutions which will help to detect, monitor and assess early treatment for cancer. Its research and development are focused on the role that metabolomics plays in early cancer detection.
Website
Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Healthcare Technology Systems
Stock Exchange
CNQ
Primary Office
- 165 - 10551 Shellbridge Way
- Richmond, British Columbia V6X 2W8
- Canada
+1 (604) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Biomark Diagnostics’s full profile, request a free trial.
Biomark Diagnostics Stock Performance
| 52 wk Range | Market Cap | Prev. Close | EPS | Average Volume | Shares |
|---|---|---|---|---|---|
| $0.03 - $0.08 | $2.38M | $0.04 | 7.74K | 62.8M |
Biomark Diagnostics Financials Summary
|
In Thousands,
USD |
TTM
30-Sep-2018
|
FY 2018
31-Mar-2018
|
FY 2017
31-Mar-2017
|
FY 2016
31-Mar-2016
|
|---|---|---|---|---|
| Enterprise Value | 2,789 | 3,313 | 3,865 | 5,956 |
| Revenue | 0 | 0 | 0 | |
| EBITDA | (464) | (566) | (545) | (1,068) |
| Net Income | (464) | (566) | (545) | (1,068) |
| Total Assets | 36 | 40 | 30 | 26 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Biomark Diagnostics Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore Biomark Diagnostics‘s full profile, request access.
Request full access to PitchBook